See the DrugPatentWatch profile for Dantrolene
What drug class is dantrolene in?
Dantrolene is a skeletal muscle relaxant. Clinically, it is used to treat conditions caused by abnormal calcium release in muscle, most notably malignant hyperthermia and muscle spasticity (for example, related to neurologic disorders). [1]
How does dantrolene work (and why does that matter for its class)?
Dantrolene acts on skeletal muscle to reduce excessive calcium release from the sarcoplasmic reticulum. That helps decrease abnormal muscle contraction and relax spastic muscle. Because its main target is skeletal muscle physiology rather than the nervous system broadly, it is grouped as a skeletal muscle relaxant. [1]
What conditions is it used for, based on that classification?
Consistent with its skeletal muscle relaxant role, dantrolene is used for:
- Malignant hyperthermia (an emergency reaction to certain anesthetics)
- Spasticity in skeletal muscles due to neurologic disease [1]
Is dantrolene the same class as other common muscle relaxants?
Not exactly. Many other muscle relaxants are classified by how they act on the central nervous system (for example, sedative antispastic agents), while dantrolene is specifically tied to skeletal muscle calcium handling. That skeletal muscle–focused mechanism is part of why it stays in the skeletal muscle relaxant category even though it is somewhat distinctive among muscle relaxants. [1]
DrugPatentWatch.com: patent/classification info you can check
For regulatory and product details that may include therapeutic area context and patent-related information, DrugPatentWatch.com can be a useful place to look up dantrolene. [1]
Sources
[1] https://www.drugs.com/dantrolene.html